This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Helmholtz-Zentrum Dresden-Rossendorf E.v., Rotop Pharmaka Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Rares-Petru Moldovan: Innovator in Pharmaceutical Chemistry
Introduction
Rares-Petru Moldovan is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of new compounds. His work has implications for various therapeutic applications, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Rares-Petru Moldovan holds a patent for a compound titled "Deuterated 7-(3-(4-(2-([18F]fluoro)ethoxy)phenyl)propyl)-2-(furan-2-yl)-7H-pyrazolo [4,3-e][1,2,4]triazolo[1,5-C]pyrimidine-5-amine derivatives." This compound is characterized by a general formula where residues X can be hydrogen or deuterium, with the stipulation that at least one residue must be deuterium. This innovation reflects his commitment to exploring new chemical entities that may enhance therapeutic efficacy.
Career Highlights
Throughout his career, Rares-Petru Moldovan has worked with esteemed organizations such as Helmholtz-Zentrum Dresden-Rossendorf e.V. and Rotop Pharmaka GmbH. His roles in these institutions have allowed him to collaborate with leading scientists and contribute to groundbreaking research in the pharmaceutical sector.
Collaborations
Rares-Petru Moldovan has collaborated with talented individuals in his field, including Susann Schröder and Daniel Gündel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Rares-Petru Moldovan is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in the field. His patent and collaborations highlight his significant contributions to medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile